NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Yes, we are excitedly and confidently awaiting their verdict. And the issues were addressed and caused by limitations in technology and understanding and ethical requirements. They were properly and adequately addressed by appropriate changes, not “manipulations” (you can’t manipulate survival data in this case), and I expect those changes were implemented with the guidance and advice of their regulators.

The best run trials, like this one, it is typical to stay in close contact with regulators during the trial, and even if it is not formal advice and there are no guarantees from those at the agencies, it is still likely, in my opinion, that they were discussing and confirming procedures with regulators every step of the way as well as with their legal counsel.

Advising post data lock from bulletin boards, Hygro, won’t change the results.